Amicus Therapeutics
FOLD
FOLD
195 hedge funds and large institutions have $2.18B invested in Amicus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 68 increasing their positions, 62 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $2.76B → $2.18B (-$577M)
24% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 33
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
195
Holding in Top 10
6
Calls
$11.4M
Puts
$2.72M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$21.7M | |
| 3 | +$21.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.1M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$9.92M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$17.1M | |
| 3 | -$15.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$14.5M |